Table 1.
Variables | n |
---|---|
No. of patients | 33 |
Age (years) | |
Median (range) | 59 (32–84) |
Gender | |
Male/female | 20/13 |
Performance status (PS)a | |
0/1/2/3 | 4/19/5/4 |
Weight lossa | |
Yes/no | 26/4 |
Jaundicea | |
Yes/no | 9/22 |
Surgery typeb | |
Whipple surgery/palliative surgery | 5/3 |
Pathologic tumor (pT) sizea | |
< Small (< 40 mm)/≥ large (≥ 40 mm) | 14/14 |
Site of lesion | |
Head/corpus-tail | 21/10 |
Response to chemotherapy (CTx) | |
Yes (PR + SD)/no (PD) | 9/11 |
Metastasis | |
Yes/no | 23/10 |
Erythrocyte sedimentation rate (ESH) | |
Normal (< 40/h)/high (> 40/h) | 11/12 |
White blood cell count (WBC)a | |
Normal (< 10.000/mm3)/high (> 10.000/mm3) | 22/9 |
Hemoglobin (Hb)a | |
Low (< 12 g/dL)/normal (> 12 g/dL) | 12/19 |
Platelet count (PLT)a | |
Low (< 150.000/mm3)/normal (> 150.000/mm3) | 5/26 |
Lactate dehydrogenase (LDH)a | |
Normal (< 450 IU/L)/high (> 450 IU/L) | 21/8 |
Albumina | |
Low (< 4 gr/dL)/normal (> 4 gr/dL) | 10/17 |
Carcinoembryonic antigen (CEA)a | |
Normal (< 5 ng/mL)/high (> 5 ng/mL) | 19/10 |
Carbohydrate antigen (CA 19.9)a | |
Normal (< 38 U/mL)/high (> 38 U/mL) | 7/22 |
Patients with unknown data concerning the variables are not included in the analysis.
In 10 patients with non-metastatic disease.